December 18, 2007
By:
George Koroneos, Online Content & News Editor
GlaxoSmithKline locks up MediaCom as its only ad-buying/planning provider. The agency will handle GSK's massive ad spend, which last year hovered around $1.1 billion.
|
December 18, 2007
By:
George Koroneos, Online Content & News Editor
Drug manufacturer shakes things up with new Web site that functions as an open book into the world of Vertex Pharmaceuticals. The company hopes that its transparent approach to design will be a lesson to pharma companies still fearful of online media.
|
December 5, 2007
By:
George Koroneos, Online Content & News Editor
The State of Arkansas filed suit against Risperdal manufacturer Johnson & Johnson, claiming promotion of the drug for nonmedical uses has led to increased prescriptions being written and bigger payouts by Medicaid.
|
December 5, 2007
By:
George Koroneos, Online Content & News Editor
Peer-review advocates speak out against Congressman Waxman?s stance on a new policy that would allow pharma to distribute unbiased journal articles to doctors without prior approval.
|
November 21, 2007
By:
George Koroneos, Online Content & News Editor
A physician-oriented search engine reveals its most-searched terms. Among the winners: breast and lung cancer, cortisol, and HbA1c/glycated hemoglobin. Nowhere to be seen: pharmaceutical products.
|
November 21, 2007
By:
George Koroneos, Online Content & News Editor
A new pharma-sponsored documentary chronicles one doctor?s adventure around the world as she searches for stories about living with diabetes. The program, sponsored by Novo Nordisk, enlightens viewers and offers physicians a chance to earn one AMA-approved CME credit.
|
November 21, 2007
By:
George Koroneos, Online Content & News Editor
Faced with contradictory data about the safety of the diabetes treatment, FDA asks for a black-box warning and additional trials. But how much damage will the black box do?
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
